Skip to main content
. 2019 Jan 27;11(2):54. doi: 10.3390/pharmaceutics11020054

Figure 6.

Figure 6

EVs induce DC maturation and CD8+ T-cell activation. (a) Flow cytometry and (b) MFI of DCs treated with control (saline) or EVs and with FITC–CD86 antibodies (n = 3); (c) TNF–α levels produced by DCs treated with control (saline), or EVs after incubation for 24 h at 37 °C (n = 3); (d) IFN–γ levels secreted by CD8+ T-cells interact with control (saline) or EV-treated mature DCs (n = 3).